These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20237795)

  • 21. [Effect of vincarin on the central nervous system].
    Khanov M; Kurmukov AG; Sultanov MB; Akhmedkhodzhaeva KhS
    Farmakol Toksikol; 1968; 31(5):538-41. PubMed ID: 4387717
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibitiory effects of gold(III) ions on ribonuclease and deoxyribonuclease.
    Maruyama T; Sonokawa S; Matsushita H; Goto M
    J Inorg Biochem; 2007 Jan; 101(1):180-6. PubMed ID: 17084460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of haloperidol on the central nervous system].
    Vinogradov VV; Krylov SS; Snegirev EA; Sysoeva AF; Khasabova VA
    Farmakol Toksikol; 1967; 30(2):131-4. PubMed ID: 4971063
    [No Abstract]   [Full Text] [Related]  

  • 24. Goldthioglucose-induced lesions and quantitative changes of monoamines in the rat brain.
    Ishizaki F
    Yonago Acta Med; 1974 Jun; 18(1):1-8. PubMed ID: 4156985
    [No Abstract]   [Full Text] [Related]  

  • 25. Change in sensitivity to insulin hypoglycemic convulsions after gold thioglucose treatment: time course of development.
    Luby JL; Holliday JF; Fish KW; Marrazzi MA
    J Pharmacol Exp Ther; 1981 Oct; 219(1):258-67. PubMed ID: 6793712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imidazole-stabilized gold nanoparticles induce neuronal apoptosis: an in vitro and in vivo study.
    Imperatore R; Carotenuto G; Di Grazia MA; Ferrandino I; Palomba L; Mariotti R; Vitale E; De Nicola S; Longo A; Cristino L
    J Biomed Mater Res A; 2015 Apr; 103(4):1436-46. PubMed ID: 25046830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of a gold-chloroquine complex on inflammation-related leukocyte functions and cell viability. Comparison with auranofin.
    Navarro M; Fraile G; Velásquez M; González E; Escalona J; Ilanjian R; Abad MJ; Taylor P
    Arzneimittelforschung; 2006; 56(12):826-33. PubMed ID: 17260670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of ketamine on the developing central nervous system.
    Vutskits L; Gascon E; Kiss JZ
    Ideggyogy Sz; 2007 Mar; 60(3-4):109-12. PubMed ID: 17451049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metallic gold beads in hyaluronic acid: a novel form of gold-based immunosuppression? Investigations of the immunosuppressive effects of metallic gold on cultured J774 macrophages and on neuronal gene expression in experimental autoimmune encephalomyelitis.
    Pedersen DS; Tran TP; Smidt K; Bibby BM; Rungby J; Larsen A
    Biometals; 2013 Jun; 26(3):369-85. PubMed ID: 23653168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of the antihistamine preparation, phencarol, on the central nervous system].
    Kaminka ME; Roshchina LF; Mashkovskiĭ MD
    Farmakol Toksikol; 1980; 43(2):148-53. PubMed ID: 6108233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Newer stimulant drugs.
    LEAKE CD
    Am J Nurs; 1958 Jul; 58(7):966-8. PubMed ID: 13545224
    [No Abstract]   [Full Text] [Related]  

  • 32. Early vascular changes in the brain of the mouse after injections of goldthioglucose and bipiperidyl mustard.
    Caffyn ZE
    J Pathol; 1972 Jan; 106(1):49-56. PubMed ID: 5035738
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effects of gold therapy on experimental inflammation caused by formalin].
    MICCOLI G; MICCOLIS G; ANGIOLINI G
    Reumatismo; 1961; 13():261-75. PubMed ID: 14473305
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of antiepileptic drugs on the developing central nervous system.
    Ransom BR; Elmore JG
    Adv Neurol; 1991; 55():225-37. PubMed ID: 2003409
    [No Abstract]   [Full Text] [Related]  

  • 35. 21st annual meeting of the American College of Neuropsychopharmacology--1982--Poster session.
    Psychopharmacol Bull; 1983; 19(4):576-777. PubMed ID: 6635132
    [No Abstract]   [Full Text] [Related]  

  • 36. The association of metal ion exposure with alpha-synuclein-like immunoreactivity in the central nervous system of fish, Catostomus commersoni.
    Boudreau HS; Krol KM; Eibl JK; Williams LD; Rossiter JP; Palace VP; Ross GM
    Aquat Toxicol; 2009 May; 92(4):258-63. PubMed ID: 19342108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central nervous system penetration for small molecule therapeutic agents does not increase in multiple sclerosis- and Alzheimer's disease-related animal models despite reported blood-brain barrier disruption.
    Cheng Z; Zhang J; Liu H; Li Y; Zhao Y; Yang E
    Drug Metab Dispos; 2010 Aug; 38(8):1355-61. PubMed ID: 20427691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental and clinical vectors in pharmacology.
    Masserman JH
    Curr Psychiatr Ther; 1976; 16():107-16. PubMed ID: 991623
    [No Abstract]   [Full Text] [Related]  

  • 39. The effects of Group 11 transition metals, including gold, on ethylene binding to the ETR1 receptor and growth of Arabidopsis thaliana.
    Binder BM; Rodriguez FI; Bleecker AB; Patterson SE
    FEBS Lett; 2007 Oct; 581(26):5105-9. PubMed ID: 17931631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symposium on comparative neuropharmacology. Gifu, Japan, July 1981.
    Comp Biochem Physiol C Comp Pharmacol; 1982; 72(2):159-414. PubMed ID: 6128135
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.